Work

Interprovider Variation in Initiation of Bone-Modifying Agents for Patients With Prostate Cancer

Year: 2025

Type: article

Study design: Observational Study

Source: JCO Oncology Practice

DOI: 10.1200/op-25-00457

Authors: Aaron P. Mitchell, Andrew Salner, Paul Palyca, Azeez Farooki, Sonia Persaud, Nirjhar Chakraborty, Dedipya Bhamidipati, Maria Klimchuk, Michaela A. Dinan, Michael S. Leapman, Allison Lipitz-Snyderman, Anis Hamid, Jamie S. Ostroff, Michael J. Morris

Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, Hartford Hospital, Lehigh Valley Health Network, University of Pittsburgh, SUNY Downstate Health Sciences University, Yale University

Language: English

Topic: Bone health and treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: G876475942, Cancer Center Support Grant, Clinical and Translational Science Award, Clinical and Translational Science Center

OpenAlex ID: W4415827133

FWCI:

Cites: 19

Cited by:

Related to: